Therapies for Migraine Headache- Free CME for Physicians

migraine2The Emerging Science of Prophylactic Therapies for Migraine– Patients with frequent migraines and/or who experience functional disability need preventative migraine treatment. However, studies have shown that of the 38% of patients who stand to benefit from prophylactic therapy, only 3-13% of them actually receive it. Calcitonin gene-related peptide (CGRP) monoclonal antibodies are under clinical investigation and constitute a new prophylactic migraine therapy class. Increased physician attention when individualizing treatment plans to maximize therapy efficacy and minimize side effects as well as managing headache triggers and existing comorbidities continue to be vital strategies as new agents emerge and when maximizing patient function.
Illustrate how to factor multiple patient-specific characteristics into the treatment plan when managing migraines.
Examine and discuss the emerging science associated with calcitonin gene related peptide (CGRP) monoclonal antibodies (mAbs) and their role in migraine prevention.
Highlight strategies and tools to assess the impact of migraine on daily functioning and quality of life in order to generate a more personalized and inclusive treatment plan.

1.0 Free AMA Pra CAT 1 CME for Physicians

Expires 12/29/17

achlme logo
This activity is supported by an educational grant from Lilly
Advertisements
This entry was posted in Physician and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s